Ftse Mib
34.544,44
-0,17%
DAX
18.689,72
-0,20%
S&P 500
5.321,41
0,25%
NASDAQ
16.832,62
0,22%
Bitcoin
70.139,33
0,01%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aerie Pharmaceuticals Inc (AERI) Aerie Pharmaceuticals Inc (AERI) Notizie

AERI

Aerie Pharmaceuticals (AERI)

HOME News News di Agenzia

News di Agenzia

Da:
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AERI
DataOraFonteTitoloSimboloCompagnia
01/12/202221:08Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:AERIAerie Pharmaceuticals Inc
22/11/202207:01Business WireAlcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company’s Ophthalmic Pharmaceutical BusinessNASDAQ:AERIAerie Pharmaceuticals Inc
21/11/202222:58Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AERIAerie Pharmaceuticals Inc
21/11/202217:47Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AERIAerie Pharmaceuticals Inc
21/11/202216:03Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AERIAerie Pharmaceuticals Inc
10/11/202222:09Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:AERIAerie Pharmaceuticals Inc
04/11/202216:15TipRanksNeedham Remains a Hold on Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
04/11/202211:02Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:AERIAerie Pharmaceuticals Inc
07/10/202215:07Edgar (US Regulatory)Proxy Statement - Merger or Acquisition (definitive) (defm14a)NASDAQ:AERIAerie Pharmaceuticals Inc
05/10/202204:18TipRanksUBX vs. AERI: Which Eyecare Stock Has the Most Upside Potential?NASDAQ:AERIAerie Pharmaceuticals Inc
04/10/202223:17ValueWalkSmall-Cap Catalyst Pharmaceuticals Is Among Market’s Best Price PerformersNASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202223:16Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202216:11TipRanksWhat Does Aerie Buyout Mean for Alcon (NYSE:ALC)?NASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202212:42Dow Jones NewsAerie Pharmaceuticals Shares Rise 34% After Alcon Buyout OfferNASDAQ:AERIAerie Pharmaceuticals Inc
23/08/202203:18Business WireAlcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical PortfolioNASDAQ:AERIAerie Pharmaceuticals Inc
05/08/202212:41TipRanksNeedham Sticks to Their Buy Rating for Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
09/05/202212:29TipRanksAerie Pharma (AERI) Gets a Buy Rating from H.C. WainwrightNASDAQ:AERIAerie Pharmaceuticals Inc
06/05/202211:16TipRanksNeedham Thinks Aerie Pharma’s Stock is Going to RecoverNASDAQ:AERIAerie Pharmaceuticals Inc
26/04/202222:22Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:AERIAerie Pharmaceuticals Inc
13/04/202221:05TipRanksNeedham Maintains a Buy Rating on Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
25/02/202213:11Edgar (US Regulatory)Annual Report (10-k)NASDAQ:AERIAerie Pharmaceuticals Inc
09/02/202219:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:AERIAerie Pharmaceuticals Inc
03/01/202210:06TipRanksWall Street Analysts Are Bullish on Top Healthcare PicksNASDAQ:AERIAerie Pharmaceuticals Inc
31/12/202117:45TipRanksNeedham Keeps Their Buy Rating on Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
16/12/202117:50TipRanksNeedham Sticks to Its Buy Rating for Aerie Pharma (AERI)NASDAQ:AERIAerie Pharmaceuticals Inc
03/12/202119:15TipRanksAerie Pharma (AERI) Gets a Buy Rating from NeedhamNASDAQ:AERIAerie Pharmaceuticals Inc
08/11/202122:20Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:AERIAerie Pharmaceuticals Inc
21/10/202122:01Business WireAerie Pharmaceuticals Announces Presentation at the Ophthalmology Innovation Summit Glaucoma Innovation ShowcaseNASDAQ:AERIAerie Pharmaceuticals Inc
20/10/202115:11Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:AERIAerie Pharmaceuticals Inc
12/10/202112:30Business WireAerie Pharmaceuticals Announces Positive Phase 3 Topline Results for Netarsudil Ophthalmic Solution 0.02% Clinical Trial in JapanNASDAQ:AERIAerie Pharmaceuticals Inc
 Ti mostriamo gli articoli più rilevanti per la tua ricerca:NASDAQ:AERI

La tua Cronologia

COIN
NOIAEUR
Syntropy [NOIA Token]
USOTC
CFNB
California First Leasing (QX)
Delayed Upgrade Clock
Per accedere al tempo reale push di Borsa è necessario registrarsi.

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network